These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 30277471)
21. Increased expression of immune checkpoint programmed cell death protein-1 (PD-1) on T cell subsets of bone marrow aspirates in patients with B-Lymphoblastic leukemia, especially in relapse and at diagnosis. Park SH; You E; Park CJ; Cho YU; Jang S; Im HJ; Seo JJ; Park HS; Lee JH Cytometry B Clin Cytom; 2020 Jul; 98(4):336-347. PubMed ID: 32268011 [TBL] [Abstract][Full Text] [Related]
22. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767 [TBL] [Abstract][Full Text] [Related]
23. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J Front Immunol; 2020; 11():590072. PubMed ID: 33329575 [TBL] [Abstract][Full Text] [Related]
24. The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia. Qorraj M; Bruns H; Böttcher M; Weigand L; Saul D; Mackensen A; Jitschin R; Mougiakakos D Leukemia; 2017 Feb; 31(2):470-478. PubMed ID: 27479178 [TBL] [Abstract][Full Text] [Related]
25. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. Hsu J; Hodgins JJ; Marathe M; Nicolai CJ; Bourgeois-Daigneault MC; Trevino TN; Azimi CS; Scheer AK; Randolph HE; Thompson TW; Zhang L; Iannello A; Mathur N; Jardine KE; Kirn GA; Bell JC; McBurney MW; Raulet DH; Ardolino M J Clin Invest; 2018 Oct; 128(10):4654-4668. PubMed ID: 30198904 [TBL] [Abstract][Full Text] [Related]
26. Frequency and functional characterization of exhausted CD8 Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177 [TBL] [Abstract][Full Text] [Related]
27. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928 [TBL] [Abstract][Full Text] [Related]
28. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia. Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179 [TBL] [Abstract][Full Text] [Related]
29. PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas. Wang Y; Wu L; Tian C; Zhang Y Ann Hematol; 2018 Feb; 97(2):229-237. PubMed ID: 29128997 [TBL] [Abstract][Full Text] [Related]
30. CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders. Cuenca M; Sintes J; Lányi Á; Engel P Clin Immunol; 2019 Jul; 204():43-49. PubMed ID: 30522694 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Study of PD-1/PD-L1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation. Masoud R; Eladl AE; El-Ashwah S; Abbas A; Kandil W Asian Pac J Cancer Prev; 2023 Dec; 24(12):4243-4252. PubMed ID: 38156860 [TBL] [Abstract][Full Text] [Related]